Search Results - "Tomokazu KORESAWA"

Population Pharmacokinetics of Tebipenem Pivoxil (ME1211), a Novel Oral Carbapenem Antibiotic, in Pediatric Patients with Otolaryngological Infection or Pneumonia by Sato, Nobuo, Kijima, Koji, Koresawa, Tomokazu, Mitomi, Nayu, Morita, Jun, Suzuki, Hisashi, Hayashi, Hiroyuki, Shibasaki, Shigeki, Kurosawa, Tohru, Totsuka, Kyoichi

“…Tebipenem pivoxil (TBPM-PI, ME1211) has been under development as the world's first oral carbapenem for treatment of otolaryngological/respiratory infections…”
Get full text

Mrp2 is involved in benzylpenicillin-induced choleresis by Ito, Kousei, Koresawa, Tomokazu, Nakano, Koichi, Horie, Toshiharu

“…Benzylpenicillin (PCG; 180 micromol/kg), a classic beta-lactam antibiotic, was intravenously given to Sprague-Dawley (SD) rats and multidrug…”
Get more information

Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study by Kato, Seiji, Cho, Naoki, Koresawa, Tomokazu, Otake, Kazunari, Kano, Akiko

“…A novel, oral phosphodiesterase 4 (PDE4) inhibitor, ME3183, is under development for the treatment of psoriasis, atopic dermatitis, and other inflammatory…”
Get full text

Population Pharmacokinetic Analyses for Arbekacin after Administration of ME1100 Inhalation Solution by Lakota, Elizabeth A, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Bhavnani, Sujata M, Ambrose, Paul G, Rubino, Christopher M

“…ME1100, an inhalation solution of arbekacin, an aminoglycoside, is being developed for the treatment of hospital-acquired and ventilator-associated bacterial…”
Get full text

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution by Bhavnani, Sujata M, Hammel, Jeffrey P, Lakota, Elizabeth A, Safir, M Courtney, VanScoy, Brian D, Nagira, Yu, Rubino, Christopher M, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Ambrose, Paul G

“…ME1100 (arbekacin inhalation solution) is an inhaled aminoglycoside that is being developed to treat patients with hospital-acquired and ventilator-associated…”
Get full text

Population Pharmacokinetics of Tebipenem Pivoxil(ME1211), a Novel Oral Carbapenem Antibiotic, in Pediatric Patients with Otolaryngological Infection or Pneumonia by Nobuo SATO, Koji KIJIMA, Tomokazu KORESAWA, Nayu MITOMI, Jun MORITA, Hisashi SUZUKI, Hiroyuki HAYASHI, Shigeki SHIBASAKI, Tohru KUROSAWA, Kyoichi TOTSUKA

“…[Summary]:Tebipenem pivoxil(TBPM-PI, ME1211)has been under development as the world's first oral carbapenem for treatment of otolaryngological/respiratory…”
Get full text

1392. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Inhaled ME1100 Dose Selection by Bhavnani, Sujata M, Hammel, Jeffrey P, Lakota, Elizabeth A, VanScoy, Brian D, Nagira, Yu, Rubino, Christopher M, Sato, Nobuo, Koresawa, Tomokazu, Kondo, Kenichiro, Ambrose, Paul G

“…Abstract Background ME1100 (arbekacin inhalational solution) is an inhaled aminoglycoside being developed to treat patients with hospital-acquired and…”
Get full text